CN Patent

CN103347519A — 使用cns 7056(雷米马唑仑)镇静的给药方案

Assigned to Wuhan Humanwell Innovative Drug Research and Development Center Ltd Co · Expires 2013-10-09 · 13y expired

What this patent protects

本发明涉及使用速效苯并二氮杂 类化合物CNS 7056与阿片样物质，特别是芬太尼组合用于镇静的给药方案，其中以2～10毫克，优选4～9毫克，最优选5～8毫克的剂量给予CNS 7056。

USPTO Abstract

本发明涉及使用速效苯并二氮杂 类化合物CNS 7056与阿片样物质，特别是芬太尼组合用于镇静的给药方案，其中以2～10毫克，优选4～9毫克，最优选5～8毫克的剂量给予CNS 7056。

Drugs covered by this patent

Patent Metadata

Patent number
CN103347519A
Jurisdiction
CN
Classification
—
Expires
2013-10-09
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Humanwell Innovative Drug Research and Development Center Ltd Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.